CA2103040A1 - Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent - Google Patents

Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent

Info

Publication number
CA2103040A1
CA2103040A1 CA002103040A CA2103040A CA2103040A1 CA 2103040 A1 CA2103040 A1 CA 2103040A1 CA 002103040 A CA002103040 A CA 002103040A CA 2103040 A CA2103040 A CA 2103040A CA 2103040 A1 CA2103040 A1 CA 2103040A1
Authority
CA
Canada
Prior art keywords
purpurogallin
blood
composition
vivo
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002103040A
Other languages
English (en)
French (fr)
Inventor
Tai-Wing Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2103040A1 publication Critical patent/CA2103040A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002103040A 1991-05-16 1992-05-15 Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent Abandoned CA2103040A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70104791A 1991-05-16 1991-05-16
US701,047 1991-05-16

Publications (1)

Publication Number Publication Date
CA2103040A1 true CA2103040A1 (en) 1992-11-17

Family

ID=24815854

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002103040A Abandoned CA2103040A1 (en) 1991-05-16 1992-05-15 Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent

Country Status (6)

Country Link
EP (1) EP0584148A1 (ja)
JP (1) JPH06507610A (ja)
AU (1) AU1745592A (ja)
CA (1) CA2103040A1 (ja)
HU (1) HUT66375A (ja)
WO (1) WO1992020332A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892157A (ja) * 1994-05-02 1996-04-09 F Hoffmann La Roche Ag プルプロガリン誘導体
ES2570152T3 (es) * 2008-06-25 2016-05-17 Basf Se Uso de derivados benzotropolona como absorbentes de UV y antioxidantes y su uso en filtros solares y/o composiciones cosméticas
KR101748806B1 (ko) 2016-02-29 2017-06-19 대구대학교 산학협력단 Purpurogallin을 유효성분으로 함유하는 멜라닌 생성 억제 화장료 조성물 및 그 제조방법
KR102040230B1 (ko) * 2017-09-25 2019-11-04 제주대학교 산학협력단 푸르푸로갈린을 포함하는, 활성산소종, 자외선 또는 미세먼지에 대한 피부 보호용 화장료 조성물
CN110128290B (zh) * 2019-05-10 2022-04-29 江苏耐雀生物工程技术有限公司 红倍酚苯甲酰肼衍生物、中间体、制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181545A (en) * 1977-04-28 1980-01-01 United Technologies Corporation Hydroxylic aromatic compounds as additives for rubber-based, composite solid propellants
US4919915A (en) * 1987-03-03 1990-04-24 Paul Averback Method for detecting the ability to prevent red-to-green congophilic birefringence
JPH01501791A (ja) * 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド 薬理学的に活性な化合物およびそれらの混合物、有機組成物および金属塩類
DK36389A (da) * 1988-02-05 1989-08-06 Eastman Kodak Co Praeparat og fremgangsmaade til at forebygge vaevskader ved reperfusion

Also Published As

Publication number Publication date
HUT66375A (en) 1994-11-28
HU9303246D0 (en) 1994-03-28
AU1745592A (en) 1992-12-30
WO1992020332A1 (en) 1992-11-26
EP0584148A1 (en) 1994-03-02
JPH06507610A (ja) 1994-09-01

Similar Documents

Publication Publication Date Title
Meerson et al. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart
Cavarocchi et al. Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E?
Schoenberg et al. Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damage
Babizhayev et al. Lipid peroxide and reactive oxygen species generating systems of the crystalline lens
Mickle et al. Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction
Drossos et al. Deferoxamine cardioplegia reduces superoxide radical production in human myocardium
Sokol et al. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids
JOHNSON III et al. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion
Bautista et al. Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin
Deneke et al. Transient depletion of lung glutathione by diethylmaleate enhances oxygen toxicity
MANABE et al. Effects of essential oils on erythrocytes and hepatocytes from rats and dipalmitoyl phosphatidylcholine-liposomes
Ouriel et al. Protection of the kidney after temporary ischemia: free radical scavengers
Sasaki et al. A protective role for glutathione-dependent reduction of dehydroascorbic acid in lens epithelium.
Jiménez et al. Protective effects of boldine against free radical‐induced erythrocyte lysis
Lawlor et al. Astaxanthin: antioxidant effects in chicken embryo fibroblasts
AU5282493A (en) Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
US4039682A (en) Method and composition for relief of back pain
US5047395A (en) Reduction of oxyradical damage in biomedical applications
Gehring et al. The cataractogenic activity of chemical agents
WO1999008514A1 (en) Compositions containing polyethylene glycol and uses thereof
CA2103040A1 (en) Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent
Chakraborty et al. Effect of erythropoietin on membrane lipid peroxidation, superoxide dismutase, catalase, and glutathione peroxidase of rat RBC
JPH01265022A (ja) 哺乳動物の組織を再潅流損傷から守る組成物及び方法
US5248668A (en) Use of purpurogallin and glycosides thereof in treating ischemia in mammals
US5099012A (en) Chroman-2-carboxamide conjugates and their use for treatment of reperfusion injury

Legal Events

Date Code Title Description
FZDE Dead